Nazira Mojadidi, MD
Interventional Pain Medicine Physician in Modesto, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,528 in Interventional Pain Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Nazira Mojadidi, MD filed 414 Medicare Part D claims in 2023 as a Interventional Pain Medicine Physician in Modesto, California, prescribing 85% generic.
- 414
- Part D claims, 2023
- 85%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Nazira Mojadidi, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
414 Top 38% higher than 62% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Nazira Mojadidi, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Nazira Mojadidi, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Interventional Pain Medicine Physician compares to other specialties among California providers
Interventional Pain Medicine Physician ranks #244 among California's specialties (0% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Interventional Pain Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Interventional Pain Medicine Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Nazira Mojadidi, MD appears in the CMS NPPES registry as a Interventional Pain Medicine Physician provider holding MD credentials at 1400 FLORIDA AVE STE 200, Modesto, CA, 95350, with a listed phone of (209) 576-3528. NPI 1477180438 was issued on 03/26/2020.
Medicare Part D records for calendar year 2023 show 414 prescription claims written by this provider, covering 80 Medicare beneficiaries and totaling roughly $40K in drug spend, split 12% brand-name and 85% generic by claim count.
Interventional Pain Medicine Physician is a narrow specialty nationwide, with 1,528 enrolled providers across 53 states and an average of 2,197 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1477180438 |
|---|---|
| Specialty | Interventional Pain Medicine Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/26/2020 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Nazira Mojadidi, MD's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1477180438 is the unique 10-digit identifier CMS uses to link Mojadidi across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Nazira Mojadidi, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Nazira Mojadidi, MD. Source: openpaymentsdata.cms.gov.
Total received
$199
Largest payer
Nevro Corp.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Nazira Mojadidi, MD. To verify Nazira Mojadidi, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
12% brand-name claims vs 85% generic, on 414 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 871
- Total Day Supply
- 25,454
- Brand vs Generic
- 12% brand / 85% generic
- Brand Drug Cost
- $32K
- Generic Drug Cost
- $5K
Patient Demographics
- Average Patient Age
- 64.4 years
- Avg HCC Risk Score
- 1.55
- Gender Split
- 75% female / 25% male
- Age Distribution
- <65: 34, 65-74: 35, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Nazira Mojadidi, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
40 claims
- Lisinopril
Lisinopril
32 claims
- Amlodipine Besylate
Amlodipine Besylate
31 claims
- Metformin Hcl 15
Metformin Hcl
15 claims
- Carvedilol 14
Carvedilol
14 claims
- Gabapentin 14
Gabapentin
14 claims
- Losartan Potassium 12
Losartan Potassium
12 claims
- Cyclobenzaprine Hcl 11
Cyclobenzaprine Hcl
11 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 40 |
| Lisinopril | 32 |
| Amlodipine Besylate | 31 |
| Metformin Hcl | 15 |
| Carvedilol | 14 |
| Gabapentin | 14 |
| Losartan Potassium | 12 |
| Cyclobenzaprine Hcl | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Interventional Pain Medicine Physician Overview
How Nazira Mojadidi, MD fits within the Interventional Pain Medicine Physician landscape nationally.
Nazira Mojadidi, MD's 414 claims are below the specialty average of 2,197.
Nearby Interventional Pain Medicine Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Mojadidi.
Compare Interventional Pain Medicine Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Interventional Pain Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is Nazira Mojadidi, MD's specialty? ▼
How much does Nazira Mojadidi, MD prescribe under Medicare Part D? ▼
Where is Nazira Mojadidi, MD located? ▼
What is Nazira Mojadidi, MD's NPI number? ▼
Does Nazira Mojadidi, MD prescribe more brand-name or generic drugs? ▼
How many Interventional Pain Medicine Physician providers are there in the US? ▼
What drugs does Nazira Mojadidi, MD prescribe most often? ▼
Does Nazira Mojadidi, MD accept Medicare? ▼
How can I verify Nazira Mojadidi, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology